SKI Market

Indian Indices

Sensex

83,277.15 650.39
( 0.79%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

56,974.47 32.50
(0.06%)

Nikkei 225

10,471.28 24.93
(0.24%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

610.0166926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

24.7

29320.88

EPS(TTM)

Face Value()

Div & Yield %

72.04

1.01

Back

simplex papers ltd

ISL Consulting reports standalone net loss of Rs 0.65 crore in the September 2025 quarter

Nov 13,2025

Net loss of ISL Consulting reported to Rs 0.65 crore in the quarter ended September 2025 as against net profit of Rs 0.26 crore during the previous quarter ended September 2024. Sales declined 26.75% to Rs 5.64 crore in the quarter ended September 2025 as against Rs 7.70 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5.64	7.70	-27
OPM %	-11.70	3.90	-
PBDT	-0.64	0.42	PL
PBT	-0.65	0.41	PL
NP	-0.65	0.26	PL

83,277.15 650.39 ( 0.79%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

56,974.47 32.50 (0.06%)

10,471.28 24.93 (0.24%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)